INFLUENCE OF SELECTED POSITIONS ON HIP ABDUCTORS STRENGTH AND ACTIVATION IN PATELLOFEMORAL PAIN SYNDROME IN MALES (PFPS)

December 13, 2025 updated by: Mohamed Gouda Mohamed, Ahram Canadian University
The study aims to explore the effect of body position (side-lying versus standing) on hip abductors muscle strength and activation in individuals with and without PFPS and then to compare these measures between the two groups in each position

Study Overview

Status

Not yet recruiting

Detailed Description

A cross-sectional comparative study involving 44 subjects (22 subjects with PFPS and 22 healthy controls), aged 18-35 years. The study will measure hip abductor muscle strength (Peak torque, Maximal total work) using the Biodex Isokinetic System 4 PRO and muscle activity (%MVC) of the gluteus medius, gluteus maximus, and tensor fascia lata using Surface EMG (Noraxon Ultium EMG). Measurements will be taken in both standing and side-lying positions.

Study Type

Observational

Enrollment (Estimated)

44

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

44 subjects, divided into 22 subjects with PFPS and 22 healthy controls, recruited from the outpatient clinics and staff/students of Ahram Canadian University

Description

Inclusion Criteria:

  • Age 18-35 years; Normal BMI; Subjects in the PFPS group diagnosed with unilateral PFPS by an orthopedist; Healthy individuals without knee pain (for the control group)

Exclusion Criteria:

  • History of lower limb surgery; Any neurological disorders; Musculoskeletal disorders affecting the lower limb; Additional sources of anterior knee pain (tendonitis, Osgood-Schlatter, bursitis, etc.); Any inflammatory diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
PFPS Group
Subjects with unilateral PFPS diagnosed by an orthopedist; age 18-35 years; normal BMI
Control Group
Healthy individuals without knee pain; age 18-35 years; normal BMI

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle activity (%MVC) of the gluteus medius, gluteus maximus, and tensor fascia lata
Time Frame: During the assessment procedure (single time point)
using SEMG
During the assessment procedure (single time point)
Peak torque (Nm) of hip abductors muscles
Time Frame: During the assessment procedure (single time point)
using isokinetic
During the assessment procedure (single time point)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal total work (J) during concentric and eccentric contractions
Time Frame: During the assessment procedure (single time point)
Using Isokinetic
During the assessment procedure (single time point)
The Arabic Version of the Kujala Score (Anterior Knee Pain Scale)
Time Frame: Baseline/Pre-assessment
A questionnaire
Baseline/Pre-assessment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: mohamed gouda mohamed, bachelor of physical therapy, Teaching assistant, Department of Physiotherapy, Department of Physical Therapy for Musculoskeletal Disorders and its Surgery, Faculty of Physical Therapy, Ahram Canadian University, Giza, Egypt

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 15, 2025

Primary Completion (Estimated)

January 15, 2026

Study Completion (Estimated)

February 15, 2026

Study Registration Dates

First Submitted

December 13, 2025

First Submitted That Met QC Criteria

December 13, 2025

First Posted (Actual)

December 26, 2025

Study Record Updates

Last Update Posted (Actual)

December 26, 2025

Last Update Submitted That Met QC Criteria

December 13, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Cairo University (Other Identifier: Cairo University)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

no specific reason

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain (PFPS)

Subscribe